Balaraman, K. Et Al. 2023. Design, synthesis and biological evaluation of Nucleosidic CD99 inhibitors that selectively reduce Ewing sarcoma viability. European Journal of Medicinal Chemistry , vol.251 .

Balaraman, K., Deniz, E., Nelson, E., Pilicer, S. L., Atasoy, S., Molotkova, A., ... Sevim Akan, H.(2023). Design, synthesis and biological evaluation of Nucleosidic CD99 inhibitors that selectively reduce Ewing sarcoma viability. European Journal of Medicinal Chemistry , vol.251.

Balaraman, Kaluvu Et Al. "Design, synthesis and biological evaluation of Nucleosidic CD99 inhibitors that selectively reduce Ewing sarcoma viability," European Journal of Medicinal Chemistry , vol.251, 2023

Balaraman, Kaluvu Et Al. "Design, synthesis and biological evaluation of Nucleosidic CD99 inhibitors that selectively reduce Ewing sarcoma viability." European Journal of Medicinal Chemistry , vol.251, 2023

Balaraman, K. Et Al. (2023) . "Design, synthesis and biological evaluation of Nucleosidic CD99 inhibitors that selectively reduce Ewing sarcoma viability." European Journal of Medicinal Chemistry , vol.251.

@article{article, author={Kaluvu Balaraman Et Al. }, title={Design, synthesis and biological evaluation of Nucleosidic CD99 inhibitors that selectively reduce Ewing sarcoma viability}, journal={European Journal of Medicinal Chemistry}, year=2023}